Skip to content

Medical-device intelligence

LFZ: Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus

FDA product code LFZ: Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LFZ
FDA device name
Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
Device class
2
Regulation number
866.3175
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

58 clearance records and 9 recall records in the covered releases, across 36 source company names and 1 product codes. Dated history runs from Dec 28, 1982 to Nov 3, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202501
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LFZ · Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus589

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

67 matching records
Device / recordCompany in FDA recordSourceSource date
Environmental Pollutants Profile TestZ-0758-2026 · LFZGET TESTED INTERNATIONAL ABRecallDec 1, 2025FDA classification date
CMV IgM EIA, in vitro diagnostic.Z-0342-2023 · LFZBio-Rad Laboratories, Inc.RecallDec 6, 2022FDA classification date
Architect CMV IgGK220949 · LFZAbbott Laboratories510(k)Oct 27, 2022FDA decision date
Elecsys CMV IgGK220911 · LFZRoche Diagnostics510(k)Oct 12, 2022FDA decision date
ADVIA Centaur CMV IgG and ADVIA Centaur CMV IgG Quality ControlK181213 · LFZSiemens Healthcare Diagnostics, Inc.510(k)Jul 30, 2018FDA decision date
Elecsys CMV IgMK163569 · LFZRoche Diagnostics510(k)Mar 17, 2017FDA decision date
VIDAS 3 software v. 1.1.4Z-1200-2017 · LFZBioMerieux SARecallFeb 14, 2017FDA classification date
LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control SetK162969 · LFZDiaSorin, Inc.510(k)Jan 6, 2017FDA decision date
Diamedix Is-CMV IgG Test KitZ-1689-2016 · LFZDiamedix CorporationRecallMay 17, 2016FDA record creation date
ELECYS CMV IGM IMMUNOASSAY; ELECYS PRECICONTROL CMV IGMK142133 · LFZRoche Diagnostics510(k)Oct 24, 2014FDA decision date
ELECSYS PRECICONTROL CMV IGG, ELECSYS CMV IGG IMMUNOASSAYK131605 · LFZRoche Diagnostics510(k)Feb 28, 2014FDA decision date
AxSYM CMV IgG Reagent Pack; Abbott Laboratories, Abbott Park, IL 60064; The AxSYM CMV IgG assay is a Microparticle Enzyme Immunoassay (MEIA) for …Z-1047-2009 · LFZAbbott LaboratoriesRecallApr 15, 2009FDA classification date
AxSYM CMV IgG Reagent Pack; list 04B47; 100 test pack; in-vitro diagnostic; Abbott Laboratories, Abbott Park, IL 60064Z-1033-200 · LFZAbbott LaboratoriesRecallJul 11, 2007FDA classification date
DIASORIN LIAISON CMV IGM/IGGK040290 · LFZDiasorin S.P.A510(k)Jun 1, 2005FDA decision date
VIDAS CMV IgG AssayZ-1047-04 · LFZbioMerieuxRecallJul 20, 2004FDA classification date
Cytomegalovirus (CMV) IgG ELISA Test System, In-Vitro Diagnostic, manufactured by Zeus Scientific, Inc., Raritan, NJ.Z-1095-03 · LFZZeus Scientific IncRecallAug 12, 2003FDA classification date
Premier CMV IgG Elisa Kits, EIA diagnostic test kits, 96 tests per kit, Catalog Numbers: 620096 and 9Z9501G.Z-1127-03 · LFZMeridian Bioscience IncRecallAug 12, 2003FDA classification date
IMMULITE 2000 CMV IGG, MODEL L2KCV2, L2KCV6K993952 · LFZDiagnostic Products Corp.510(k)Dec 16, 1999FDA decision date
SERAQUEST CMV IGMK982485 · LFZQuest Intl., Inc.510(k)Jan 13, 1999FDA decision date
THE APTUS (AUTOMATED) APPLICATION OF THE CMV IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THEK984139 · LFZZeus Scientific, Inc.510(k)Jan 11, 1999FDA decision date
THE APTUS (AUTOMATED) APPLICATION OF THE CMV IGM ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THEK983803 · LFZZeus Scientific, Inc.510(k)Dec 14, 1998FDA decision date
MODIFICATION TO COPALIS CMV TOTAL ANTIBODY ASSAYK982027 · LFZDiaSorin, Inc.510(k)Nov 25, 1998FDA decision date
DIAMEDIX IS-CMV IGG TEST SYSTEMK981163 · LFZDiamedix Corp.510(k)Sep 21, 1998FDA decision date
QUANTA LITE CMV IGG ELISAK971335 · LFZInova Diagnostics, Inc.510(k)Dec 1, 1997FDA decision date
ABBOTT CMV TOTAL ANTIBODY EIA (MODIFICATION)K954301 · LFZAbbott Laboratories510(k)Mar 24, 1997FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗